Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating skin tissue damage by topically administering a bi-specific protein comprising a human insulin-like growth factor variant and a human annexin A5 variant

Method of treating skin tissue damage by topically administering a bi-specific protein comprising a human insulin-like growth factor variant and a human annexin A5 variant

US Patent 12122819 · Granted Oct 22, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activatable fusion protein and use thereof2024
Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nu2024
Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nu2024
Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nu2024
Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nu2024
Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nu2024
Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nu2024
Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nu2024
Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nu2024
Bi-specific fusion proteins2023
Bi-specific fusion proteins2023
Method of inhibiting apoptosis or promoting cell survival by providing a bi-spec2021